You're in a planning meeting, and the choice is already uncomfortable. Buy a genomic risk platform and inherit another vendor contract, another integration queue, and another dashboard nobody trusts. Build a lean in-house pipeline, and you own the data model, the consent logic, and the clinical workflow, but you